title: Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.
authors.forename: Homayoun
authors.initials: H
authors.lastname: Khanlou
authors.forename: Laveeza
authors.initials: L
authors.lastname: Bhatti
authors.forename: Charles
authors.initials: C
authors.lastname: Farthing
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D002219:Carbamates; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D010755:Organophosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D017211:Treatment Failure; D014766:Viremia / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents; D002219:Carbamates; D005663:Furans; D009842:Oligopeptides; D010755:Organophosphates; D011725:Pyridines; D013449:Sulfonamides; D000069446:Atazanavir Sulfate; C095108:amprenavir; C426859:fosamprenavir